The effect of antioxidant on development of fibrosis by cisplatin in rats

Journal of Pharmacological Sciences

Volumn 111, Issue 4, 2009, Pages 433-439

  Kawai, Yoshiko ^a   Satoh, Tomohiko ^a   Hibi, Daisuke ^a   Ohno, Yukihiro ^a   Kohda, Yuka ^a   Miura, Katsuyuki ^b   Gemba, Munekazu ^c  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c YOKOHAMA COLLEGE OF PHARMACY   (Japan)

Author keywords

Cisplatin; Interstitial fibrosis; Macrophage; Oxidative stress; Renal injury

Indexed keywords

CISPLATIN; COLLAGEN TYPE 3; CREATININE; N,N' DIPHENYL 1,4 PHENYLENEDIAMINE; NITROGEN; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE COURSE; DISEASE EXACERBATION; DRUG INHIBITION; ENZYMURIA; FIBROSING ALVEOLITIS; MALE; NONHUMAN; RAT; UREA NITROGEN BLOOD LEVEL;

EID: 74849110331     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.09185FP     Document Type: Article

References (29)

1. Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW. Mechanism of cis-platinum nephrotoxicity: II. Morphologic observations. J Pharmacol Exp Ther. 1980;213:551-556.
2. Chopra S, Kaufman JS, Jones TW, Hong WK, Gehr MK, Hamburger RJ, et al. Cis-diamminedichloroplatinum-induced acute renal failure in the rat. Kidney Int. 1982;21:54-64.
3. Gemba M, Fukuishi N, Nakano S. Effect of N-N'-diphenyl -p-phenylenediamine pretreatment on urinary enzyme excretion in cisplatin nephrotoxicity in rats. Jpn J Pharmacol. 1988;46:90-92.
4. Greggi Antunes LM, Darin JD, Bianchi MD. Protective effects of vitamin C against cisplatin-induced nephrotoxicity and lipid peroxidation in adult rats: a dose-dependent study. Pharmacol Res. 2000;41:405-411.
5. Nakano S, Gemba M. Potentiation of cisplatin-induced lipid peroxidation in kidney cortical slices by glutathione depletion. Jpn J Pharmacol. 1989;50:87-92.
6. 2 production in cisplatin-induced nephrotoxicity. Biochem Biophys Res Commun. 1998;242:310-312.
7. Guinee DG Jr, van Zee B, Houghton DC. Clinically silent progressive renal tubulointerstitial disease during cisplatin chemotherapy. Cancer. 1993;71:4050-4054.
8. Dobyan DC. Long-term consequences of cis-platinum-induced renal injury: a structural and functional study. Anat Rec. 1985;212:239-245.
9. Nangaku M. Mechanisms of tubulointerstitial injury in the kidney final common pathways to end-stage renal failure. Intern Med. 2004;43:9-17.
10. Sugihara K, Nakano S, Koda M, Tanaka K, Fukuishi N, Gemba M. Stimulatory effect of cisplatin on production of lipid peroxidation in renal tissues. Jpn J Pharmacol. 1987;43:247-252.
11. Matsunaga Y, Kawai Y, Kohda Y, Gemba M. Involvement of activation of NADPH oxidase and extracellular signal-regulated kinase (ERK) in renal cell injury induced by zinc. J Toxicol Sci. 2005;30:135-144.
12. Rangan G, Tesch GH. Quantification of renal pathology by image analysis. Nephrology. 2007;12:553-558.
13. Nakatani T, Tamada S, Asai T, Iwai Y, Kim T, Miura K, et al. Role of renin-angiotensin system and nuclear factor-κB in the obstructed kidney of rats with unilateral ureteral obstruction. Jpn J Pharmacol. 2002;90:361-364.
14. Hartley DP, Kroll DJ, Petersen DR. Prooxidant-intiated lipid peroxidation in isolated rat hepatocytes: detection of 4-hydroxy-nonenal-and malondialdehyde-protein adducts. Chem Res Toxicol. 1997;10:895-905.
15. Sato S, Yamate J, Saito T, Hosokawa T, Saito S, Kurasaki M. Protective effect of taurine against renal interstitial fibrosis of rats induced by cisplatin. Naunyn Schmiedebergs Arch Pharmacol. 2002;365:277-283.
16. Sato S, Hori Y, Yamate J, Saito T, Kurasaki M, Hatai A. Protective effect of dietary azuki bean (Vigna angularis) seed coats against renal interstitial fibrosis of rats induced by cisplatin. Nutrition. 2005;21:504-511.
17. Shen B, Hagiwara M, Yao YY, Chao L, Chao J. Salutary effect of kallistatin in salt-induced renal injury, inflammation, and fibrosis via antioxidative stress. Hypertension. 2008;51:1358-1365.
18. Duru M, Nacar A, Yönden Z, Kuvandik G, Helvaci MR, Koc A, et al. Protective effects of N-acetylcysteine on cyclosporine-A-induced nephrotoxicity. Ren Fail. 2008;30:453-459.
19. Bhatti F, Mankhey RW, Asico L, Quinn MT, Welch WJ, Maric C. Mechanisms of antioxidant and pro-oxidant effects of alphalipoic acid in the diabetic and nondiabetic kidney. Kidney Int. 2005;67:1371-1380.
20. Lee HB, Yu MR, Yang Y, Jiang Z, Ha H. Reactive oxygen species-regulated signaling pathways in diabetic nephropathy. J Am Soc Nephrol. 2003;14: S241-S245.
21. Sean Eardley K, Cockwell P. Macrophages and progressive tubulointerstitial disease. Kidney Int. 2005;68:437-455.
22. Tamada S, Asai T, Kuwabara N, Iwai T, Uchida J, Teramoto K, et al. Molecular mechanisms and therapeutic strategies of chronic renal injury: the role of nuclear factor kappaB activation in the development of renal fibrosis. J Pharmacol Sci. 2006;100:17-21.
23. Cruz CM, Rinna A, Forman HJ, Ventura AL, Persechini PM, Ojcius DM. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem. 2007;282:2871-2879.
24. Rodríguez-Iturbe B, Vaziri ND, Herrera-Acosta J, Johnson RJ. Oxidative stress, renal infiltration of immune cells, and salt-sensitive hypertension: all for one and one for all. Am J Physiol Renal Physiol. 2004;286:F606-F616.
25. Morimoto Y, Gai Z, Tanishima H, Kawakatsu M, Itoh S, Hatamura I, et al. TNF-α deficiency accelerates renal tubular interstitial fibrosis in the late stage of ureteral obstruction. Exp Mol Pathol. 2008;85:207-213.
26. Ricardo SD, Diamond JR. The role of macrophages and reactive oxygen species in experimental hydronephrosis. Semin Nephrol. 1998;18:612-621.
27. Nakamura K, Oka M, Shirai M, Igarashi Y, Kojima K, Kaneko O, et al. Source of reactive oxygen species in anti-Thy1 nephritis. Ren Fail. 1998;20:399-405.
28. Ng YY, Huang TP, Yang WC, Chen ZP, Yang AH, Mu W, et al. Tubular epithelial-myofibroblast transdifferentiation in progressive tubulointerstitial fibrosis in 5/6 nephrectomized rats. Kidney Int. 1998;54:864-876.
29. Yang T, Vesey DA, Johnson DW, Wei MQ, Gobe GC. Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapies. Trans Res. 2007;150:40-50.